India: Patent

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
India's New Form-10 Requirement: What Businesses Using Foreign Biological Resources Must Know
The National Biodiversity Authority (NBA) has issued a notification on February 04, 2026 to clarify the obligation to submit a Declaration in Form-10 by any person intending to use any biological resource or associated traditional knowledge, obtained from a foreign country in India. This article provides an overview of the new requirement and its implications for businesses and research institutions.
India Commercial
SR
S.S. Rana & Co. Advocates
Article
Designs – Graphic User Interface Satisfies Criteria Of A Design And Is Eligible For Registration Under Designs Act
The Calcutta High Court has ruled that Graphic User Interfaces (GUIs) qualify as protectable designs under India's Designs Act, 2000, rejecting the Controller's narrow interpretation that excluded digital interfaces from registration. The landmark decision establishes that GUIs reflect creative aesthetic choices in visual elements like icons, menus, and color palettes that can be judged by the eye, and clarifies that the term 'article' requires broad interpretation...
India IP
LS
Lakshmikumaran & Sridharan
Article
Mapping Matters: Why Patent Litigation Demands Technical Precision
The High Court of Delhi recently delivered a significant judgment in the matter of Mold-Tek Packaging Limited v. Neway Industries Pvt. Ltd. The case revolves around two key patents held by Mold-Tek regarding container closure systems: IN 401417 (for a “Tamper-Evident Leak Proof Pail Closure System”) and IN 298724 (for a “Tamper Proof Lid Having Spout for Containers and Process for Its Manufacture”).
India IP
SR
S.S. Rana & Co. Advocates
Article
When Public Interest Tempers Interim Patent Relief: The Nivolumab Biosimilar Ruling
In Zydus Lifesciences Ltd. v. E.R. Squibb and Sons LLC & Ors. (FAO(OS) (COMM) 120/2025, CM APPL. 44383/2025, CM APPL. 44386/2025 & CM APPL. 44388/2025), the Division Bench of the Delhi High Court modified the interim order passed by the Single Judge, who had restrained Zydus from manufacturing, using, offering for sale, selling or importing its biosimilar version of the cancer immunotherapy drug Nivolumab in India.
India IP
RS
Remfry & Sagar
See more